# Wheeze and Intermittent Treatment

> **NCT01142505** · PHASE3 · COMPLETED · sponsor: **Queen Mary University of London** · enrollment: 1358 (actual)

## Conditions studied

- Wheezing

## Interventions

- **DRUG:** Mannitol
- **DRUG:** Montelukast

## Key facts

- **NCT ID:** NCT01142505
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 1358 (ACTUAL)
- **Last updated:** 2014-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01142505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01142505, "Wheeze and Intermittent Treatment". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01142505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*